A detailed history of High Tower Trust Services, Lta transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, High Tower Trust Services, Lta holds 4,148 shares of GILD stock, worth $350,879. This represents 0.03% of its overall portfolio holdings.

Number of Shares
4,148
Previous 4,148 -0.0%
Holding current value
$350,879
Previous $356,000 3.37%
% of portfolio
0.03%
Previous 0.03%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 07, 2022

BUY
$59.54 - $68.01 $246,971 - $282,105
4,148 New
4,148 $256,000
Q2 2022

Jul 22, 2022

SELL
$57.72 - $65.01 $438,729 - $494,141
-7,601 Closed
0 $0
Q1 2022

Apr 21, 2022

BUY
$57.92 - $72.58 $2,548 - $3,193
44 Added 0.58%
7,601 $452,000
Q4 2021

Jan 14, 2022

BUY
$64.88 - $73.64 $490,298 - $556,497
7,557 New
7,557 $549,000
Q4 2020

Jan 29, 2021

SELL
$56.65 - $64.55 $688,750 - $784,798
-12,158 Closed
0 $0
Q3 2020

Oct 19, 2020

SELL
$62.1 - $78.08 $200,520 - $252,120
-3,229 Reduced 20.99%
12,158 $768,000
Q2 2020

Jul 17, 2020

SELL
$72.34 - $84.0 $50,638 - $58,800
-700 Reduced 4.35%
15,387 $1.18 Million
Q1 2020

Apr 16, 2020

BUY
$62.63 - $80.22 $35,824 - $45,885
572 Added 3.69%
16,087 $1.2 Million
Q4 2019

Jan 27, 2020

SELL
$61.62 - $67.78 $165,018 - $181,514
-2,678 Reduced 14.72%
15,515 $1.01 Million
Q3 2019

Oct 23, 2019

BUY
$62.51 - $69.0 $67,010 - $73,968
1,072 Added 6.26%
18,193 $1.15 Million
Q2 2019

Jul 29, 2019

BUY
$61.87 - $69.38 $106,849 - $119,819
1,727 Added 11.22%
17,121 $1.16 Million
Q1 2019

Apr 29, 2019

BUY
$62.53 - $70.05 $8,253 - $9,246
132 Added 0.86%
15,394 $1 Million
Q4 2018

Jan 28, 2019

SELL
$60.54 - $79.0 $284,477 - $371,221
-4,699 Reduced 23.54%
15,262 $955,000
Q3 2018

Oct 24, 2018

BUY
$71.28 - $78.92 $52,034 - $57,611
730 Added 3.8%
19,961 $1.54 Million
Q2 2018

Jul 31, 2018

BUY
$64.88 - $75.68 $1.25 Million - $1.46 Million
19,231 New
19,231 $1.36 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $106B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track High Tower Trust Services, Lta Portfolio

Follow High Tower Trust Services, Lta and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Trust Services, Lta, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Trust Services, Lta with notifications on news.